Los Angeles, CA -- (SBWire) -- 02/17/2019 --Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.
Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
The global Hepatitis A Vaccine market is valued at 650 million US$ in 2018 is expected to reach 760 million US$ by the end of 2025, growing at a CAGR of 2.1% during 2019-2025.
Get PDF template of this report: https://www.qyresearch.com/sample-form/form/965668/global-hepatitis-a-vaccine-market
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
Kaketsuken
IMBCA
ChangSheng
Convac
Segment by Type
Inactivated Vaccine
Live Attenuated Vaccine
Segment by Application
Government Institution
Private Sector
Get Complete Report in your Inbox within 24 hours: https://www.qyresearch.com/settlement/pre/40b738e56a5690727db13b69f22b7a76,0,1,Global%20Hepatitis%20A%20Vaccine%20Market%20Development%20and%20Forecast%20Report%202019
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Hepatitis a Vaccine Market Registers Enormous Growth Rate During the Forecast Period, 2019–2025
Hepatitis A Vaccine Market Report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry, by summing up the previous growth patterns, the growth drivers and the current and future trends.